Non-Invasive Glucose Monitoring Market Size, Share, Growth, and Industry Growth, By Type (Wearable Blood Glucose Monitoring Systems and Table Top Blood Glucose Monitoring Systems), By Application (Hospitals, Clinics, and Others), Regional Forecast By 2031

Updated On: 15 April 2024

Non-Invasive Glucose Monitoring Market Report Overview

• 

• Request a Free Sample to learn more about this report

The global non-invasive glucose monitoring market size is USD 191.2 million in 2022, as per our research, the market is projected to touch USD 296.48 million by 2031, exhibiting a CAGR of 17.3% during the forecast period.

The global COVID-19 pandemic has been unprecedented and staggering, with non-invasive glucose monitoring experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden spike in CAGR is attributable to demand returning to pre-pandemic levels once the pandemic is over.

The devices used for measuring glucose levels in the patient's body are non-invasive glucose monitoring devices. It measures a patient's blood glucose levels without stinging the skin, extracting blood, or inflicting pain or trauma. They are often designed for patients with diabetes mellitus. The painless, non-invasive, and monitoring technique of these devices is helping them acquire popularity among the juvenile and elderly populations. Additionally, increasing R&D spending and initiatives that result in developing cutting-edge and affordable products will improve the industry picture in the near future.

Products for bloodless glucose monitoring are anticipated to play a significant role in developing revolutionary wearable digital health solutions for the diabetes industry. In recent years, there has been a sharp rise in the usage of minimally invasive and non-invasive monitoring technologies, such as continuous glucose monitoring. The precision with which equipment can identify hypoglycemic episodes is still unknown. This systematic review and meta-analysis evaluated the diagnostic adequacy of minimally invasive, non-invasive hypoglycemia detection in patients with type 1 or type 2 diabetes compared to capillary or venous blood glucose.

COVID-19 Impact: Rising Health Concerns During Pandemic Outbreak Benefited Market

The non-invasive glucose monitoring market benefited from COVID-19 last year due to the higher risk of infection and consequences in diabetic patients. The need for self-monitoring devices in home settings was sparked by limits on travel and movement and a lack of hospital beds. In addition, as people's demands for real-time results and their health awareness developed, the cost of healthcare during the pandemic grew, encouraging the industry's growth.

LATEST TRENDS

"Rising Prevalence of Diabetes to Surge the Market Growth"

The prevalence of diabetes is rising alarmingly worldwide, necessitating constant monitoring of blood glucose levels. Monitoring blood sugar levels continuously is a useful strategy for managing and preventing problems associated with diabetes. Non-invasive glucose monitoring is a term used to measure or monitor blood glucose levels without the need for blood sampling or skin piercing. Blood samples were drawn as part of the traditional monitoring procedure, which was uncomfortable. Therefore, several advancements have been developed, which are anticipated to increase the non-invasive glucose monitoring market.

Non-Invasive Glucose Monitoring Market Segmentation

• 

• Request a Free Sample to learn more about this report

• By Type Analysis

By type, the market is segmented into wearable blood glucose monitoring systems and tabletop blood glucose monitoring systems.

Wearable blood glucose monitoring devices are estimated to hold the lion's share in the global market due to the rising prevalence of diabetes among the general population. The wearable is developing more quickly, and because of its rapid growth, it is predicted to have a larger market in the future. The industry has been strengthened for future times due to the vast array of innovations and goods being introduced into the market by major players and manufacturers. Growing public awareness of the system's benefits and drawbacks is enabling the market to achieve outstanding achievements. 

• By Application Analysis

Based on application, the market is classified into hospitals, clinics, and others. 

DRIVING FACTORS

"Less Painful Treatment Offered by These Devices to Cater to Device Demand"

Non-invasive glucose monitoring reduces the need for painful finger pricking, which increases the risk of infection and the amount of tissue damage done to the finger. The expansion of a market for non-invasive blood glucose monitoring devices throughout the projection period is expected as non-invasive glucose monitoring holds tremendous promise for enhancing diabetes treatment by offering improved and painless blood glucose measurement.

"Constant Health Checkups to Assess Patients to Foster Market Growth"

The population is more concerned about healthy living and is inclined toward choosing the best course of therapy and diet. A continuous monitoring system aids in continuously assessing the patient's status. The market will grow in the next few years as more people get diabetes, primarily due to factors that contribute to diabetes, which will further raise the demand for monitoring devices. The pandemic outbreak boosted the population’s concern about health, which increased the population’s visits to the hospital, which is anticipated to aid non-invasive glucose monitoring market growth.

RESTRAINING FACTORS

"Low Accuracy of the Monitoring Devices to Hamper Growth"

Lower accuracy of the monitoring device is anticipated to affect the non-invasive monitoring market growth. The repeatability of algorithms is expected to be an additional factor in hindering the growth of the market. 

Non-Invasive Glucose Monitoring Market Regional Insights

• 

• Request a Free Sample to learn more about this report

"North America to Lead the Global Market Due to the Rapid Adoption of Advanced Devices"

North America is anticipated to hold a leading part of the non-invasive glucose monitoring market share owing to the steady adoption of advanced technologies. The rising demand for wearable devices is also expected to boost regional product demand. 

Europe is anticipated to hold a significant market share due to the growing sedentary lifestyle, coupled with active government support. Moreover, the rising number of start-ups providing healthcare devices is also expected to prosper market growth.

KEY INDUSTRY PLAYERS

"Key Players Focusing On Innovative Technology Development to Grow in Market"

Businesses are working on developing new technology to offer more easy ways to increase product portfolio. Companies also use innovative practices and techniques to create new technologies. Companies are focused on acquisitions and investments to increase sales. The marketplace is competitive as a result of the existence of numerous huge firms. An extensive worldwide consumer base and the execution of operations through specialized distribution networks are other characteristics. The key companies strive to gain a higher market share by launching new products. 

List of Market Players Profiled

• Abbott (U.S.)
• Medtronic (Ireland)
• Roche (Switzerland)
• Bayer AG (Germany)
• B. Braun (Germany)
• Nipro Diagnostics (Japan)
• Life Scan Inc.(J&J) (U.S.)
• Arkray Devices (Japan)
• Nova Biomedical (U.S.)
• Bionime Corporation (China)
• Sinocare (China)
• Hybio Pharmaceutical (China)
• Lepu Medical (China)
• Yuyue Medical (China)

REPORT COVERAGE

The market research study offers thorough information on numerous market aspects. The growth drivers, restraints, geographical analysis, competitive environment, and challenges are a few of them. Additionally, it provides an analytical analysis of market trends and projections for stem cells to show potential investment areas. From 2017 through 2031, the market is objectively assessed to determine its financial viability. The report's data was compiled using a variety of primary and secondary sources.